Cubilin (CUBN) antibody labeling of mouse kidney epithelium
Cubilin proteins are found in the endocytic vesicles of the epithelium lining the S3 segment of the proximal tubule (counterstained with LTL) in the mouse kidney.
$155.00 – $435.00
Anti-Cubilin (CUBN) antibody is validated on mouse tissue and recommended for immunofluorescence labeling, IHC, or western blot of materials from rodent and human tissues.
Anti-Cubilin (CUBN) antibody is validated on mouse tissue and recommended for immunofluorescence labeling, IHC, or western blot of materials from rodent and human tissues.
Cubilin is encoded by the CUBN gene in human. Cubilin (CUBN) acts as a receptor for the endocytosis of intrinsic factor-vitamin B12 complexes. Cubilin is located within the epithelium of intestine and kidney. Mutations in the CUBN gene may play a role in autosomal recessive megaloblastic anemia.
Host/Isotype: Rat/IgG
Class: Polyclonal
Immunogen: Synthetic peptide (18-aa) derived from the internal region of mouse Cubilin protein
Species homology of immunogen: Synthetic peptide sequence is identical to rat sequence (showing 94.4% homology to human sequence)
Conjugation: Unconjugated
Purification: Affinity chromatography
Storage buffer: PBS, pH 7.2, 0.1% sodium azide
Storage condition: –20°C
For Research Use Only. Not for use in clinical diagnostics.
You must be logged in to post a review.
Item Cat No.: 31051
Antibody: Rat VAMP1 (SYB1) Polyclonal Antibody
Concentration: 0.25 mg/ml purified IgG
Application: Validated by immunofluorescence labeling (1:100)
Reactivity: Human, mouse, rat
Read More
Best Seller
Item Cat No.: 31011
Antibody: Rat LRP1 Polyclonal Antibody
Concentration: 0.25 mg/ml purified IgG
Application: Validated by immunofluorescence labeling (1:100)
Reactivity: Human, mouse, rat
Read More
Item Cat No.: 31702
Antibody: Rat MFSD2A (NLS1) (C-terminus) Polyclonal Antibody
Concentration: 0.25 mg/ml purified IgG
Application: Validated by immunofluorescence labeling (1:100)
Reactivity: Human, mouse, rat
Read More
Reviews
There are no reviews yet.